Aspen Pharmacare Holdings Limited (APNHF)
USD 12.25
(0.04%)
USD 12.25
(0.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.22 Billion | 5.52 Billion | 5.37 Billion | 6.82 Billion | 8.26 Billion | 6 Billion |
| Net Income | 6.99 Billion | 7.82 Billion | 8.67 Billion | 6.63 Billion | 7.42 Billion | 5.06 Billion |
| Depreciation & Amortization | 1.97 Billion | 1.78 Billion | 1.71 Billion | 1.65 Billion | 1.6 Billion | 1.27 Billion |
| Deferred income taxes | - | -435 Million | -1.63 Billion | -1.74 Billion | -882 Million | 1.13 Billion |
| Stock-based compensation | 117 Million | 135 Million | 58 Million | 67 Million | 49 Million | 37 Million |
| Change in working capital | -242 Million | -3.35 Billion | -2.65 Billion | 648 Million | 192 Million | -1.37 Billion |
| Other non-cash items | -1.74 Billion | -432 Million | -780 Million | -434 Million | -122 Million | -133 Million |
| Investing Cash Flow | -9.46 Billion | -3.42 Billion | -2.16 Billion | 9.76 Billion | 1.62 Billion | 3.23 Billion |
| Investments in PPE | -5.53 Billion | -3.18 Billion | -2.69 Billion | -3.43 Billion | -2.69 Billion | -3.58 Billion |
| Acquisitions | -911 Million | 317 Million | 73 Million | 12.76 Billion | 3.94 Billion | 12.29 Billion |
| Investment purchases | - | - | 2.69 Billion | - | - | - |
| Sales/Maturities of investments | - | - | 90 Million | - | - | - |
| Other Investing Activities | -3.97 Billion | -557 Million | -2.32 Billion | 426 Million | 368 Million | -5.47 Billion |
| Financing Cash Flow | 3.62 Billion | -420 Million | -4.67 Billion | -15.64 Billion | -11.46 Billion | -11.26 Billion |
| Debt repayment | -5.4 Billion | -6.58 Billion | -15.66 Billion | -30.07 Billion | -25.47 Billion | -33.12 Billion |
| Dividends payments | -1.52 Billion | -1.45 Billion | -1.19 Billion | - | - | -1.43 Billion |
| Common Stock Repurchased | -56 Million | -136 Million | -1.85 Billion | -50 Million | -41 Million | -29 Million |
| Common Stock Issuance | - | - | - | - | - | 23.36 Billion |
| Other Financing Activities | -201 Million | 7.75 Billion | 14.03 Billion | 14.47 Billion | 14.05 Billion | -41 Million |
| Accounts receivables | -104 Million | 327 Million | -1.35 Billion | 348 Million | 1.61 Billion | 869 Million |
| Accounts payables | - | -327 Million | 1.35 Billion | -348 Million | -1.61 Billion | - |
| Inventory | 200 Million | -2.7 Billion | -2.16 Billion | -280 Million | -727 Million | -1.02 Billion |
| Other working capital | -338 Million | -657 Million | -484 Million | 928 Million | 919 Million | -1.21 Billion |
| Cash at beginning of period | 7.49 Billion | 4.97 Billion | 5.95 Billion | 5.61 Billion | 6.14 Billion | 8.11 Billion |
| Cash at end of period | 7.22 Billion | 7.49 Billion | 4.97 Billion | 5.95 Billion | 5.61 Billion | 6.14 Billion |
| Capital Expenditure | -5.53 Billion | -3.18 Billion | -2.69 Billion | -3.43 Billion | -2.69 Billion | -3.58 Billion |
| Effect of forex changes on cash | -653 Million | 843 Million | 479 Million | -602 Million | 1.05 Billion | 59 Million |
| Net cash flow / Change in cash | -273 Million | 2.52 Billion | -984 Million | 338 Million | -531 Million | -1.96 Billion |
| Free Cash Flow | 690 Million | 2.33 Billion | 2.67 Billion | 3.39 Billion | 5.57 Billion | 2.41 Billion |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 114.11 Million | 126.34 Million | 135.1 Million | 7.82 Billion | 156.69 Million | 8.67 Billion |
| Depreciation & Amortization | 56.18 Million | 51.54 Million | 49.09 Million | 1.78 Billion | 50.39 Million | 1.71 Billion |
| Deferred income taxes | - | - | - | -435 Million | - | -1.63 Billion |
| Stock-based compensation | - | - | - | 135 Million | - | 58 Million |
| Change in working capital | -8.4 Million | -4.8 Million | -62.95 Million | -3.35 Billion | -127.04 Million | -2.65 Billion |
| Other non-cash items | 43.78 Million | 64.2 Million | 178.64 Million | -432 Million | 120.77 Million | -780 Million |
| Investing Cash Flow | -180.07 Million | -336.88 Million | -96.96 Million | -3.42 Billion | -93.05 Million | -2.16 Billion |
| Investments in PPE | -88.72 Million | -155.99 Million | -109.02 Million | -3.18 Billion | -65.63 Million | -2.69 Billion |
| Acquisitions | -1.63 Million | -181.21 Million | 9.31 Million | 317 Million | -28.12 Million | 73 Million |
| Investment purchases | - | - | - | - | - | 2.69 Billion |
| Sales/Maturities of investments | - | - | - | - | - | 90 Million |
| Other Investing Activities | -32.21 Million | 327.6 Thousand | 2.75 Million | -557 Million | 703.2 Thousand | -2.32 Billion |
| Financing Cash Flow | -15.45 Million | 213.26 Million | -31.79 Million | -420 Million | 10.6 Million | -4.67 Billion |
| Debt repayment | -9.33 Million | -359.7 Million | -26.23 Million | -6.58 Billion | -108.41 Million | -15.66 Billion |
| Dividends payments | - | -83.26 Million | -211.6 Thousand | -1.45 Billion | -85.49 Million | -1.19 Billion |
| Common Stock Repurchased | -218.4 Thousand | -2.83 Million | -211.6 Thousand | -136 Million | -7.73 Million | -1.85 Billion |
| Common Stock Issuance | - | -5.13 Million | - | - | - | - |
| Other Financing Activities | -5.89 Million | -55.2 Million | -5.55 Million | 7.75 Billion | -4.57 Million | 14.03 Billion |
| Accounts receivables | - | - | - | 327 Million | - | -1.35 Billion |
| Accounts payables | - | - | - | -327 Million | - | 1.35 Billion |
| Inventory | - | - | - | -2.7 Billion | - | -2.16 Billion |
| Other working capital | -8.4 Million | -4.8 Million | - | -657 Million | - | -484 Million |
| Cash at beginning of period | 633.25 Million | 577.24 Million | 471.43 Million | 4.97 Billion | 377.16 Million | 5.95 Billion |
| Cash at end of period | 673.6 Million | 633.25 Million | 577.24 Million | 7.49 Billion | 471.43 Million | 4.97 Billion |
| Capital Expenditure | -88.72 Million | -155.99 Million | -109.02 Million | -3.18 Billion | -65.63 Million | -2.69 Billion |
| Effect of forex changes on cash | - | 45.41 Million | 32.85 Million | 843 Million | 76.69 Million | 479 Million |
| Net cash flow / Change in cash | 40.34 Million | 56 Million | 105.8 Million | 2.52 Billion | 94.27 Million | -984 Million |
| Free Cash Flow | 116.95 Million | -21.78 Million | 92.68 Million | 2.33 Billion | 34.39 Million | 2.67 Billion |
5012
SEKZF
GGAL
300001
PSTC
ECU